Cargando…
Impact of Short-Term Isoflavone Intervention in Polycystic Ovary Syndrome (PCOS) Patients on Microbiota Composition and Metagenomics
Background: Polycystic ovary syndrome (PCOS) affects 5–20% of women of reproductive age worldwide and is associated with disorders of glucose metabolism. Hormone and metabolic signaling may be influenced by phytoestrogens, such as isoflavones. Their endocrine effects may modify symptom penetrance in...
Autores principales: | Haudum, Christoph, Lindheim, Lisa, Ascani, Angelo, Trummer, Christian, Horvath, Angela, Münzker, Julia, Obermayer-Pietsch, Barbara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7656308/ https://www.ncbi.nlm.nih.gov/pubmed/32492805 http://dx.doi.org/10.3390/nu12061622 |
Ejemplares similares
-
The Salivary Microbiome in Polycystic Ovary Syndrome (PCOS) and Its Association with Disease-Related Parameters: A Pilot Study
por: Lindheim, Lisa, et al.
Publicado: (2016) -
Alterations in Gut Microbiome Composition and Barrier Function Are Associated with Reproductive and Metabolic Defects in Women with Polycystic Ovary Syndrome (PCOS): A Pilot Study
por: Lindheim, Lisa, et al.
Publicado: (2017) -
Autoimmunity to the Follicle-Stimulating Hormone Receptor (FSHR) and Luteinizing Hormone Receptor (LHR) in Polycystic Ovarian Syndrome
por: Schniewind, Hanna A., et al.
Publicado: (2021) -
Risk of Insulin Resistance and Metabolic Syndrome in Women with Hyperandrogenemia: A Comparison between PCOS Phenotypes and Beyond
por: Borzan, Valentin, et al.
Publicado: (2021) -
Natural autoantibodies to the gonadotropin-releasing hormone receptor in polycystic ovarian syndrome
por: Sattler, Lisa-Marie, et al.
Publicado: (2021)